Literature DB >> 17922940

Measuring depression: comparison and integration of three scales in the GENDEP study.

R Uher1, A Farmer, W Maier, M Rietschel, J Hauser, A Marusic, O Mors, A Elkin, R J Williamson, C Schmael, N Henigsberg, J Perez, J Mendlewicz, J G E Janzing, A Zobel, M Skibinska, D Kozel, A S Stamp, M Bajs, A Placentino, M Barreto, P McGuffin, K J Aitchison.   

Abstract

BACKGROUND: A number of scales are used to estimate the severity of depression. However, differences between self-report and clinician rating, multi-dimensionality and different weighting of individual symptoms in summed scores may affect the validity of measurement. In this study we examined and integrated the psychometric properties of three commonly used rating scales.
METHOD: The 17-item Hamilton Depression Rating Scale (HAMD-17), the Montgomery-Asberg Depression Rating Scale (MADRS) and the Beck Depression Inventory (BDI) were administered to 660 adult patients with unipolar depression in a multi-centre pharmacogenetic study. Item response theory (IRT) and factor analysis were used to evaluate their psychometric properties and estimate true depression severity, as well as to group items and derive factor scores.
RESULTS: The MADRS and the BDI provide internally consistent but mutually distinct estimates of depression severity. The HAMD-17 is not internally consistent and contains several items less suitable for out-patients. Factor analyses indicated a dominant depression factor. A model comprising three dimensions, namely 'observed mood and anxiety', 'cognitive' and 'neurovegetative', provided a more detailed description of depression severity.
CONCLUSIONS: The MADRS and the BDI can be recommended as complementary measures of depression severity. The three factor scores are proposed for external validation.

Entities:  

Mesh:

Year:  2007        PMID: 17922940     DOI: 10.1017/S0033291707001730

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  60 in total

1.  The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment.

Authors:  Thomas G Schulze; Martin Alda; Mazda Adli; Nirmala Akula; Raffaella Ardau; Elise T Bui; Caterina Chillotti; Sven Cichon; Piotr Czerski; Maria Del Zompo; Sevilla D Detera-Wadleigh; Paul Grof; Oliver Gruber; Ryota Hashimoto; Joanna Hauser; Rebecca Hoban; Nakao Iwata; Layla Kassem; Tadafumi Kato; Sarah Kittel-Schneider; Sebastian Kliwicki; John R Kelsoe; Ichiro Kusumi; Gonzalo Laje; Susan G Leckband; Mirko Manchia; Glenda Macqueen; Takuya Masui; Norio Ozaki; Roy H Perlis; Andrea Pfennig; Paola Piccardi; Sara Richardson; Guy Rouleau; Andreas Reif; Janusz K Rybakowski; Johanna Sasse; Johannes Schumacher; Giovanni Severino; Jordan W Smoller; Alessio Squassina; Gustavo Turecki; L Trevor Young; Takeo Yoshikawa; Michael Bauer; Francis J McMahon
Journal:  Neuropsychobiology       Date:  2010-05-08       Impact factor: 2.328

Review 2.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

3.  Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study.

Authors:  Heike Benes; Wolfgang Mattern; Ines Peglau; Tillmann Dreykluft; Lars Bergmann; Corinna Hansen; Ralf Kohnen; Norbert Banik; S W Schoen; Magdolna Hornyak
Journal:  J Neurol       Date:  2010-12-28       Impact factor: 4.849

4.  Evidence for multiple genetic factors underlying DSM-IV criteria for major depression.

Authors:  Kenneth S Kendler; Steven H Aggen; Michael C Neale
Journal:  JAMA Psychiatry       Date:  2013-06       Impact factor: 21.596

5.  Pharmacogenetics of antidepressive treatment.

Authors:  Astrid Zobel; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-01-03       Impact factor: 5.270

6.  Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder.

Authors:  Boadie W Dunlop; Steven P Cole; Charles B Nemeroff; Helen S Mayberg; W Edward Craighead
Journal:  J Affect Disord       Date:  2017-12-27       Impact factor: 4.839

7.  From laboratory to life: associating brain reward processing with real-life motivated behaviour and symptoms of depression in non-help-seeking young adults.

Authors:  Jindra M Bakker; Liesbet Goossens; Poornima Kumar; Iris M J Lange; Stijn Michielse; Koen Schruers; Jojanneke A Bastiaansen; Ritsaert Lieverse; Machteld Marcelis; Thérèse van Amelsvoort; Jim van Os; Inez Myin-Germeys; Diego A Pizzagalli; Marieke Wichers
Journal:  Psychol Med       Date:  2018-11-29       Impact factor: 7.723

8.  The clinical characterization of the adult patient with depression aimed at personalization of management.

Authors:  Mario Maj; Dan J Stein; Gordon Parker; Mark Zimmerman; Giovanni A Fava; Marc De Hert; Koen Demyttenaere; Roger S McIntyre; Thomas Widiger; Hans-Ulrich Wittchen
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

Review 9.  Assessing anhedonia in depression: Potentials and pitfalls.

Authors:  Sakina J Rizvi; Diego A Pizzagalli; Beth A Sproule; Sidney H Kennedy
Journal:  Neurosci Biobehav Rev       Date:  2016-03-06       Impact factor: 8.989

10.  Genome-wide linkage on chromosome 10q26 for a dimensional scale of major depression.

Authors:  Emma E M Knowles; Jack W Kent; D Reese McKay; Emma Sprooten; Samuel R Mathias; Joanne E Curran; Melanie A Carless; Marcio A A de Almeida; H H Goring Harald; Tom D Dyer; Rene L Olvera; Peter T Fox; Ravi Duggirala; Laura Almasy; John Blangero; David C Glahn
Journal:  J Affect Disord       Date:  2015-11-17       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.